News
Hyundai ADM Bio said Monday that it is working on a new drug, Penetrium, which is intended to help enhance the efficiency of ...
A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Philips’ latest UroNav version, marking an ...
Health technology company Royal Philips announced it received FDA 510 (k) clearance for its latest image-guided navigation ...
In a significant advancement for prostate cancer research, a first-of-its kind study led by Emory researchers uncovered how the disease transforms ...
Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85% ...
The NanoKnife System uses a non-thermal technique called irreversible electroporation (IRE) to ablate targeted prostate tissue while sparing critical structures. Unlike thermal ablation, IRE avoids ...
DynaCAD urology with advanced annotation UroNav cart with advanced annotation option UroNav with advanced annotation July 23, ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...
Research confirms that many men with nonmetastatic prostate cancer will not die of their disease once they received recommended treatment.
Androgen deprivation therapy is a lifesaving therapy used by thousands of men each year, but some patients are warning of ...
During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results